Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 5:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–1 of 1 matching trial from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Asymptomatic Amyloid-positive Clear all

Terminated Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia

NCT02569398

View directory record Official record

Conditions: Asymptomatic Amyloid-positive
Interventions: Atabecestat, 5 mg, Atabecestat, 25 mg, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 60 Years to 85 Years

Enrollment: 557 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 64
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 61 more

Source: ClinicalTrials.gov public record

Updated Apr 28, 2025 · Synced May 22, 2026, 5:45 AM EDT